Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Fentanyl on Expression of Main Opioid Receptor (OPRM1) on Human Granulosa Cells During Ultrasound-guided Transvaginal Oocyte Retrieval.

NCT03248076 is registered in ClinicalTrials.gov with George Papanicolaou Hospital as lead sponsor.

NCT NCT03248076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03248076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Fentanyl on Expression of Main Opioid Receptor (OPRM1) on Human Granulosa Cells During Ultrasound-guided Transvaginal Oocyte Retrieval.
Lead sponsor
George Papanicolaou Hospital
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2017
Completion date
October 10, 2018
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, stress reaction